Sumitomo Mitsui Trust Holdings Inc. Has $25.58 Million Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Sumitomo Mitsui Trust Holdings Inc. lowered its holdings in shares of Henry Schein, Inc. (NASDAQ:HSICFree Report) by 0.2% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 338,677 shares of the company’s stock after selling 566 shares during the period. Sumitomo Mitsui Trust Holdings Inc. owned about 0.26% of Henry Schein worth $25,577,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the business. Vanguard Group Inc. raised its holdings in shares of Henry Schein by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 15,171,464 shares of the company’s stock worth $1,148,632,000 after buying an additional 161,891 shares in the last quarter. American Century Companies Inc. raised its holdings in shares of Henry Schein by 7.3% during the 3rd quarter. American Century Companies Inc. now owns 4,719,088 shares of the company’s stock worth $350,392,000 after buying an additional 322,649 shares in the last quarter. Boston Partners raised its holdings in shares of Henry Schein by 144.1% during the 4th quarter. Boston Partners now owns 2,637,429 shares of the company’s stock worth $199,393,000 after buying an additional 1,556,831 shares in the last quarter. Fiduciary Management Inc. WI grew its position in Henry Schein by 17.1% during the 4th quarter. Fiduciary Management Inc. WI now owns 2,284,337 shares of the company’s stock worth $172,947,000 after acquiring an additional 333,855 shares during the last quarter. Finally, Norges Bank bought a new stake in Henry Schein during the 4th quarter worth $111,715,000. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Trading Down 0.3 %

NASDAQ HSIC opened at $64.75 on Tuesday. The business’s 50-day moving average price is $68.97 and its two-hundred day moving average price is $72.49. Henry Schein, Inc. has a 12 month low of $60.01 and a 12 month high of $82.63. The firm has a market capitalization of $8.29 billion, a PE ratio of 21.88, a price-to-earnings-growth ratio of 1.60 and a beta of 0.87. The company has a current ratio of 1.75, a quick ratio of 1.02 and a debt-to-equity ratio of 0.47.

Henry Schein (NASDAQ:HSICGet Free Report) last announced its earnings results on Tuesday, May 7th. The company reported $1.10 EPS for the quarter, beating the consensus estimate of $1.01 by $0.09. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The company had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.21 billion. During the same quarter in the prior year, the company earned $1.21 EPS. The firm’s revenue for the quarter was up 3.7% compared to the same quarter last year. On average, analysts expect that Henry Schein, Inc. will post 5.16 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages recently weighed in on HSIC. Barrington Research restated an “outperform” rating and set a $92.00 price objective on shares of Henry Schein in a research report on Friday. UBS Group reduced their price objective on Henry Schein from $82.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 8th. Finally, Piper Sandler restated an “overweight” rating and set a $86.00 price objective on shares of Henry Schein in a research report on Friday, June 21st. One analyst has rated the stock with a sell rating, six have given a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $81.73.

View Our Latest Stock Report on HSIC

Henry Schein Company Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

See Also

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.